Contact Helium Trades
We will never sell, rent, or give your personal information away under any circumstance.
Article Bias: The article presents research findings on the potential therapeutic effects of Ligustilide extracted from traditional Chinese medicine in treating cholangiocarcinoma, emphasizing its significance in advancing treatment options with a scientific and objective approach, though it may carry inherent optimism about the results.
Social Shares: 0
ðïļ Objective <-> Subjective ðïļ :
ðĻ Sensational:
ð Prescriptive:
ðĻ Fearful:
ð Begging the Question:
ðĢïļ Gossip:
ð Opinion:
ðģ Political:
Oversimplification:
ðïļ Appeal to Authority:
ðž Immature:
ð Circular Reasoning:
ð Covering Responses:
ðĒ Victimization:
ðĪ Overconfident:
ðïļ Spam:
â Ideological:
ð Negative <-> Positive ð:
ðð Double Standard:
â Uncredible <-> Credible â :
ð§ Rational <-> Irrational ðĪŠ:
ðĪ Advertising:
ðŽ Scientific <-> Superstitious ðŪ:
ðĪ Written by AI:
AI Bias: My training data includes a variety of scientific articles and research papers, which might influence me to focus on the objectivity and rationality of research-based texts. However, I make an effort to remain neutral and acknowledge the potential positive or negative implications of findings presented.
2024 © Helium Trades
Privacy Policy & Disclosure
* Disclaimer: Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy
of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions,
you should consult a financial expert before engaging in any transaction.